(Q37945039)

25 August 2017

title

Blinding in randomized clinical trials: imposed impartiality (English)

1 reference

25 August 2017

2

1 reference

25 August 2017

1

A Hróbjartsson

0 references

author name string

A Hróbjartsson

series ordinal

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

12 October 2011

1 reference

Clinical Pharmacology & Therapeutics

25 August 2017

published in

1 reference

25 August 2017

volume

90

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

732-736

1 reference

Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Acupuncture for patients with migraine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Placebo-induced changes in FMRI in the anticipation and experience of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Effect of encouragement on walking test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Reporting methods of blinding in randomized trials assessing nonpharmacological treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Towards a proposal for assessment of blinding success in clinical trials: up-to-date review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Blinding in randomised trials: hiding who got what.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

Intentional ignorance: a history of blind assessment and placebo controls in medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

7 January 2021

Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

7 January 2021

Minimizing bias in randomized trials: the importance of blinding

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

7 January 2021

Lessons learned from attempts to establish the blind in placebo-controlled trials of zinc for the common cold

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

7 January 2021

Masked monitoring in clinical trials--blind stupidity?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

7 January 2021

Hypnosis, reporting bias, and suggested negative hallucinations

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.207

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.207

1 reference

Dimensions Publication ID

25 August 2017

1029779591

0 references

1 reference